Market Cap (In EUR)
19.77 Million
Revenue (In EUR)
3.15 Million
Net Income (In EUR)
-7.03 Million
Avg. Volume
19.71 Thousand
- Currency
- EUR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.827-3.08
- PE
- -2.15
- EPS
- -0.75
- Beta Value
- 1.106
- ISIN
- FR0013296746
- CUSIP
- -
- CIK
- -
- Shares
- 12282601.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Didier Laurens
- Employee Count
- -
- Website
- https://www.advicenne.com
- Ipo Date
- 2017-12-06
- Details
- Advicenne S.A., a specialty pharmaceutical company, develops and commercializes treatments for nephrology. Its lead product candidate is Sibnayal for the treatment of distal renal tubular acidosis, as well as for the treatment of cystinuria. Advicenne S.A. was founded in 2007 and is headquartered in Paris, France.
More Stocks
-
DLUEYDe La Rue plc
DLUEY
-
600187
-
KRFGKing Resources, Inc.
KRFG
-
AMP
-
ALGIDEgide S.A.
ALGID
-
SHNWFSchroders plc
SHNWF
-
HDFCAMC
-
8085